Dr. Lynd is an epidemiologist/health outcomes researcher and a Professor in the Faculty of Pharmaceutical Sciences, University of British Columbia. He is the Director of the Collaboration for Outcomes Research and Evaluation (CORE), a Scientist at the Centre for Advancing Health Outcomes Sciences at the Providence Health Research Institute, and an Associate of the UBC School of Population and Public Health.

Dr. Lynd has more than 240 peer-reviewed publications, book chapters, and research abstracts, and he sits as the economics expert on the B.C. Ministry of Health Services Expensive Drugs for Rare Diseases Committee. His research focuses on the evaluation of drugs, health technologies, and programs across many health care areas including multiple sclerosis and rare diseases. He is currently the lead of early health technology platform of the Nanomedicines Innovation Network, the pillar lead of the epidemiology/health economics pillar of the Canadian Prospective Cohort Study to Understand Progression in Multiple Sclerosis.